BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25339765)

  • 1. Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.
    Maeda Y; Terasawa H; Tanaka Y; Mitsuura C; Nakashima K; Yusa K; Harada S
    J Virol; 2015 Jan; 89(1):502-11. PubMed ID: 25339765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV envelopes and their receptor GLUT1, the ubiquitous glucose transporter: a new vision on HTLV infection?
    Manel N; Taylor N; Kinet S; Kim FJ; Swainson L; Lavanya M; Battini JL; Sitbon M
    Front Biosci; 2004 Sep; 9():3218-41. PubMed ID: 15353351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding.
    Kim FJ; Manel N; Garrido EN; Valle C; Sitbon M; Battini JL
    Retrovirology; 2004 Dec; 1():41. PubMed ID: 15575958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection of CD4+ T lymphocytes by the human T cell leukemia virus type 1 is mediated by the glucose transporter GLUT-1: evidence using antibodies specific to the receptor's large extracellular domain.
    Jin Q; Agrawal L; VanHorn-Ali Z; Alkhatib G
    Virology; 2006 May; 349(1):184-96. PubMed ID: 16519917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: a possible implication for tropical spastic paraparesis/HTLV-I associated myelopathy.
    Mor-Vaknin N; Turgeman H; Torgeman A; Wolfson M; Huleihel M; Aboud M
    Cell Biol Int; 1998; 22(2):95-103. PubMed ID: 9878096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.
    Ghez D; Lepelletier Y; Lambert S; Fourneau JM; Blot V; Janvier S; Arnulf B; van Endert PM; Heveker N; Pique C; Hermine O
    J Virol; 2006 Jul; 80(14):6844-54. PubMed ID: 16809290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay.
    Okuma K; Nakamura M; Nakano S; Niho Y; Matsuura Y
    Virology; 1999 Feb; 254(2):235-44. PubMed ID: 9986790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLUT-1-independent infection of the glioblastoma/astroglioma U87 cells by the human T cell leukemia virus type 1.
    Jin Q; Agrawal L; Vanhorn-Ali Z; Alkhatib G
    Virology; 2006 Sep; 353(1):99-110. PubMed ID: 16781755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1.
    Al-Saleem J; Dirksen WP; Martinez MP; Shkriabai N; Kvaratskhelia M; Ratner L; Green PL
    PLoS One; 2019; 14(3):e0214059. PubMed ID: 30897179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
    Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.
    Coskun AK; Sutton RE
    J Virol; 2005 Apr; 79(7):4150-8. PubMed ID: 15767416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene.
    Costa GC; Azevedo R; Gadelha SR; Kashima SH; Muricy G; Olavarria VN; Covas DT; Takayanagui OM; Galvão-Castro B; Alcantara LC
    J Med Virol; 2009 Mar; 81(3):552-7. PubMed ID: 19152396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes.
    Blot V; Delamarre L; Perugi F; Pham D; Bénichou S; Benarous R; Hanada T; Chishti AH; Dokhélar MC; Pique C
    J Cell Sci; 2004 Aug; 117(Pt 17):3983-93. PubMed ID: 15286176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human T-cell leukemia virus type 1 replication by antisense env oligodeoxynucleotide.
    Maeda N; Kawamura T; Hoshino H; Yamada N; Blackard J; Kushida S; Miyano-Kurosaki N; Yamamoto N; Makino K; Yokota T; Uchida K; Miwa M
    Biochem Biophys Res Commun; 1998 Feb; 243(1):109-12. PubMed ID: 9473488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating human T cell lymphotropic retrovirus (HTLV) Tax function with molecular and immunophenotypic techniques.
    Forlani G; Accolla RS; Tosi G
    Methods Mol Biol; 2014; 1087():299-313. PubMed ID: 24158832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process.
    Kuo CW; Mirsaliotis A; Brighty DW
    J Immunol; 2011 Jul; 187(1):361-71. PubMed ID: 21646298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation.
    Grant C; Barmak K; Alefantis T; Yao J; Jacobson S; Wigdahl B
    J Cell Physiol; 2002 Feb; 190(2):133-59. PubMed ID: 11807819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.